PL9: 2,3-DIMETHYL-5-(3,7,11,15,19,23,27,31,35-NONAMETHYL-2,6,10,14,18,22,26,30,34-HEXATRIACONTANONAENYL-2,5-CYCLOHEXADIENE-1,4-DIONE-2,3-DIMETHYL-5-SOLANESYL-1,4-BENZOQUINONE
PL9 is a Ligand Of Interest in 4TNK designated by the RCSB
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry | |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4TNK_PL9_D_405 | 54% | 32% | 0.125 | 0.934 | 1.14 | 1.52 | 4 | 14 | 9 | 0 | 100% | 1 |
| 4TNK_PL9_d_407 | 31% | 34% | 0.15 | 0.864 | 1.08 | 1.52 | 5 | 12 | 6 | 0 | 100% | 1 |
| 4TNK_PL9_a_407 | 22% | 34% | 0.181 | 0.905 | 1.03 | 1.56 | 3 | 11 | 5 | 0 | 82% | 1 |
| 4TNK_PL9_j_101 | 13% | 32% | 0.197 | 0.904 | 1.06 | 1.6 | 2 | 9 | 0 | 0 | 64% | 1 |
| 4TNK_PL9_A_407 | 8% | 35% | 0.225 | 0.85 | 1 | 1.54 | 4 | 10 | 5 | 0 | 82% | 1 |
| 4TNK_PL9_J_101 | 7% | 32% | 0.213 | 0.867 | 1.02 | 1.64 | 3 | 9 | 0 | 0 | 64% | 1 |
| 5V2C_PL9_d_407 | 95% | 34% | 0.04 | 0.976 | 1.31 | 1.28 | 9 | 9 | 0 | 0 | 100% | 1 |
| 3WU2_PL9_d_405 | 90% | 30% | 0.047 | 0.966 | 1.27 | 1.53 | 9 | 13 | 0 | 0 | 100% | 1 |
| 5B66_PL9_D_412 | 89% | 35% | 0.049 | 0.964 | 1.09 | 1.44 | 3 | 10 | 0 | 0 | 100% | 1 |
| 7RF1_PL9_D_407 | 88% | 23% | 0.052 | 0.967 | 1.57 | 1.59 | 7 | 16 | 0 | 0 | 100% | 1 |
| 6JLJ_PL9_d_406 | 88% | 40% | 0.052 | 0.965 | 0.73 | 1.52 | 2 | 14 | 1 | 0 | 100% | 1 |
| 1VF5_PL9_Q_1305 | 88% | 3% | 0.062 | 0.984 | 3.4 | 2.39 | 21 | 16 | 31 | 0 | 100% | 1 |
